World Ovarian Cancer Day, observed on May 8, is a powerful reminder that this silence must be broken. In 2025, the campaign theme “No Woman Left Behind” underscores the global call for equity in diagnosis, treatment, and survivorship — regardless of geography, income, or background.
Cancer remains one of the leading causes of death worldwide—but
Cancer has always been viewed as a battle—one fought with surgery, chemotherapy, radiation, and advanced immunotherapies. These treatments share a common goal: destroy cancer cells before they destroy the body. But what if, instead of killing cancer cells, we could reprogram them back into healthy, normal cells?
Cancer treatment has come a long way from a one-size-fits-all approach. Today, medicine is moving towards personalized therapy—treatments tailored to the unique genetic makeup of each patient’s cancer. One of the most powerful tools driving this shift is Next Generation Sequencing (NGS).
